October 23, 2020

TB Alliance with the Support of the Republic of Korea Announce Initiative to Broaden Adoption and Scale Up of New Treatments for Drug-Resistant Tuberculosis (TB)

LIFT-TB to increase treatment completion rates for drug-resistant TB, focusing on seven high-burden Southeast and Central Asian countries that shoulder about 1 in 5 TB cases
August 3, 2020

TB Alliance Announces European Commission Authorisation of New Treatment for Highly Drug-Resistant Tuberculosis

Pretomanid, developed by the non-profit TB Alliance, has received EU marketing authorisation in combination regimen with bedaquiline and linezolid in adults with XDR-TB or treatment-intolerant/non-responsive MDR-TB
July 22, 2020

Global Health Leaders Chart the Path Forward in Pandemic Response

Dr. Anthony Fauci Calls for a Unified Approach and Continuous Commitment to Pandemic Preparedness
June 18, 2020

New Report Highlights Urgent Need for Improved Treatments for Children with MDR-TB

Tuberculosis is a leading cause of death worldwide. Children with drug-resistant TB need improved treatment options

Pages